Skip to main content
. 2021 Oct 1;100(39):e27390. doi: 10.1097/MD.0000000000027390

Table 4.

Cases of rhabdomyolysis in patients with systemic lupus erythematosus.

No Year reported Age (yr) Sex Peak Cr (mg/dL) Peak CK (IU/L) Duration (yr) Etiology Comorbidity HP (d) Clinical outcome
1 1994[9] 39 F NR 17,260 12 Discoid lupus Polymyositis 60 Remission
2 1999[10] 40 F 2.2 1,846 23 Atorvastatin, Cyclosporine Kidney transplantation 4 Remission
3 2000[11] 27 F 1.39 45,429 3 S. enteritidis bacteremia Acute cholecystitis 34 Remission
4 2005[12] 45 F NR 39,000 NR Quinacrine Dystrophic calcinosis NR Remission
5 2011[13] 36 F 4.9 75,000 13 Unspecific myositis§ Pulmonary infection 10 Death
6 2014[14] 39 F 0.91 45,265 4 Dengue fever Compartment syndrome 34 Remission
7 2018[15] 36 F 3.59 304,700 5 Gastroenteritis None NR Remission
8 2019[17] 28 F 1.2 13,776 0 Exercise, Oral contraceptive Chronic azotemia 0 Remission
9 2020[16] 25 F 2.8 13,585 NR Fungal infection Mesenteric panniculitis§ NR Death
10 Present 44 F 1.0 60,092 0 Acute hyponatremia Hypothyroidism 28 Remission

CK = creatine kinase, Cr = serum creatinine, d = days, F = female, HP = hospitalization period, No = number, NR = not reported, S = Salmonella, yr = years.

Duration of systemic lupus erythematosus prior to occurrence of rhabdomyolysis.

Initial presentation of systemic lupus erythematosus

Azotemia.

§

Autopsy.